SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-24-010648
Filing Date
2024-02-05
Accepted
2024-02-05 16:30:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D tm245223d1_sc13d.htm SC 13D 42190
  Complete submission text file 0001104659-24-010648.txt   43846
Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1 27744604171
PSYENCE BIOMEDICAL LTD. (Subject) CIK: 0001985062 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94325 | Film No.: 24596131
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE, 1300 TORONTO A6 M5H 2K1
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE, 1300 TORONTO A6 M5H 2K1 4163467764
Psyence Group Inc. (Filed by) CIK: 0002009573 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13D